ONVONTATUG VIDETECAN
UNII 5M9FD5ZCZ7

Substance Identification & Data

This profile provides standardized clinical and technical data for Onvontatug Videtecan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5M9FD5ZCZ7.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3061614-65-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
5M9FD5ZCZ7
CAS Registry Number
3061614-65-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ONVONTATUG VIDETECAN
Official standardized name for this substance within the FDA UNII nomenclature system.
INN ID
14027
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Onvontatug Videtecan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ONVONTATUG VIDETECAN

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN FOLATE RECEPTOR .ALPHA.) (HUMAN-MUS MUSCULUS MONOCLONAL BAT6028 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BAT6028 .KAPPA.-CHAIN, DIMER, REDUCED, THIOETHER WITH (2S)-2-((2-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)ACETYL)AMINO)-4-(1-OXO-4,7,10,13,16,19,22,25-OCTAOXAHEXACOS-1-YL)BUTANOYL-L-VALYL-N5-(AMINOCARBONYL)-N-(4-((((((1S,9S)-9-ETHYL-5-FLUORO-2,3,9,10,13,15-HEXAHYDRO-9-HYDROXY-4-METHYL-10,13-DIOXO-1H,12H-BENZO(DE)PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-1-YL)AMINO)CARBONYL)OXY)METHYL)PHENYL)-L-ORNITHINAMIDE
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS FOLR1 (FOLATE RECEPTOR 1, FOLATE RECEPTOR ALPHA, FR-ALPHA, ADULT FOLATE-BINDING PROTEIN, FBP, OVARIAN TUMOR-ASSOCIATED ANTIGEN MOV18)), MONOCLONAL ANTIBODY, CONJUGATED ON AN AVERAGE OF EIGHT CYSTEINYL RESIDUES TO VIDETECAN, COMPRISING A LINKER AND A CAMPTOTHECIN DERIVATIVE (ONVONTATUG VIDETECAN)
ONVONTATUG VIDETECAN [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record